Company profile for Carina Biotech

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Carina Biotech is an Australian pre-clinical immunotherapy company established to research and develop chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers. CAR-T therapy is a revolutionary new treatment option that uses a patient’s immune system to fight their cancer. Carina is developing CAR-T and other adoptive cell therapies that can be used to treat solid cancers, are patient-specific and result...
Carina Biotech is an Australian pre-clinical immunotherapy company established to research and develop chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers. CAR-T therapy is a revolutionary new treatment option that uses a patient’s immune system to fight their cancer. Carina is developing CAR-T and other adoptive cell therapies that can be used to treat solid cancers, are patient-specific and result in little, if any, off-cancer damage. Using its proprietary platforms, Carina is also developing technologies to improve access to, and infiltration of, solid cancers, and to enhance CAR-T cell manufacturing.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Australia
Address
Address
Level 2, Ian Wark (IW) Building UniSA Mawson Lakes Campus Mawson Lakes 5095
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/11/04/2974465/0/en/Bionomics-Receives-Milestone-Payment-of-AUS-1M-from-Carina-Biotech-for-BNC101-Partnered-Legacy-Oncology-Program.html

GLOBENEWSWIRE
04 Nov 2024

https://www.globenewswire.com/news-release/2024/03/18/2848138/0/en/Carina-Biotech-to-Present-Three-Poster-Presentations-at-AACR-Annual-Meeting-2024.html

GLOBENEWSWIRE
18 Mar 2024

https://www.globenewswire.com//news-release/2023/12/18/2798182/0/en/Carina-Biotech-Doses-First-Patient-in-Phase-1-2a-Clinical-Trial-of-LGR5-Targeted-CAR-T-Cell-Therapy.html

GLOBENEWSWIRE
18 Dec 2023

https://www.globenewswire.com//news-release/2023/08/21/2728607/0/en/Carina-Biotech-to-Present-Preclinical-Data-Evaluating-LGR5-Targeted-CAR-T-Cell-Therapy-in-Human-Cancer-Models-at-8th-CAR-TCR-Summit.html

GLOBENEWSWIRE
21 Aug 2023

https://www.globenewswire.com/news-release/2023/06/05/2681905/0/en/Carina-Biotech-Appoints-Two-New-U-S-Based-Biotechnology-Executives-to-the-Board-of-Directors.html

GLOBENEWSWIRE
05 Jun 2023

https://www.globenewswire.com/news-release/2023/05/24/2675746/0/en/Carina-Biotech-to-Participate-in-Three-Upcoming-Conferences.html

GLOBENEWSWIRE
24 May 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty